Significant risk factors for OS in breast cancer patients from the TCGA cohort included age (p = 1.2E-03), cancer stage (p = 1.6E-05), lymph node stage (p = 6.6E-07), distant metastasis stage (p = 0.005), and GFPT1 expression (p = 1.5E-04) (Supplementary Figure S3). This evidence concerns the gene GFPT1 and breast cancer.